QSAR studies on dihydro-alkoxy-benzyl-oxopyrimidines (DABOs) derivatives, a new series of potent, broad-spectrum non-nucleoside reverse transcriptase inhibitors
Journal Article: Journal of Current Pharmaceutical Research 01/2010; DOI: http://www.doaj.org/doaj?func=openurl&genre=article&issn=09763171&date=2010&volume=1&issue=1&spage=19
Abstract
Source: DOAJ
Comments on this publication
ResearchGate members can add comments. Sign up now and post your comment!
Similar publications
The anti-HIV activity of three 2-alkylsulfanyl-6-benzyl-3, 4-dihydropyrimidin-4 (3H)-one derivatives acting as non-nucleoside reverse transcriptase inhibitor in vitro.
Yao xue xue bao = Acta pharmaceutica Sinica. 45(2):228-34.
Synthesis, biological evaluation and molecular modeling studies of N-aryl-2-arylthioacetamides as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Chemical biology & drug design. 76(4):330-9.
Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
Bioorganic & medicinal chemistry letters. 16(13):3430-3.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.

